These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5348409)

  • 1. Effect of microsomal enzyme modifiers on toxicity and therapeutic activity of cyclophosphamide in mice.
    Hart LG; Adamson RH
    Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):391-401. PubMed ID: 5348409
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of phenobarbital or 2-diethylaminoethyl-2,2-diphenylvalerate on the activation of cyclophosphamide in vivo.
    Field RB; Gang M; Kline I; Venditti JM; Waravdekar VS
    J Pharmacol Exp Ther; 1972 Feb; 180(2):475-83. PubMed ID: 5010684
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of phenobarbital on cyclophosphamide antitumor activity.
    Alberts DS; van Daalen Wetters T
    Cancer Res; 1976 Aug; 36(8):2785-9. PubMed ID: 1277188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of phenobarbital and SKF 525A on the toxicity, elimination and metabolism of cyclophosphamide in newborn mice.
    Bus JS; Short RD; Gibson JE
    J Pharmacol Exp Ther; 1973 Mar; 184(3):749-56. PubMed ID: 4687235
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine.
    Siemann DW
    Cancer Treat Rep; 1983 Mar; 67(3):259-65. PubMed ID: 6831472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide.
    Rose WC; Trader MW; Laster WR; Schabel FM
    Cancer Treat Rep; 1978 Sep; 62(9):1337-49. PubMed ID: 688277
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of phenobarbital and SKF 525-A on the teratogenicity of cyclophosphamide in mice.
    Gibson JE; Becker BA
    Teratology; 1968 Nov; 1(4):393-8. PubMed ID: 4992685
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship of drug toxicity to chemotherapeutic effectiveness.
    Karrer K; Humphryes SR; Goldin A
    Antimicrob Agents Chemother (Bethesda); 1965; 5():539-43. PubMed ID: 5883470
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined therapy of L1210 leukemia with cyclophosphamide and lycurim.
    Stoychkov JN; Milushev AS; Todorov DK
    Neoplasma; 1980; 27(1):33-6. PubMed ID: 6892839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic performance of carminomycin-cyclophosphamide against L1210 leukemia.
    Avery TL; Cruze PG
    Cancer Res; 1978 Sep; 38(9):2892-5. PubMed ID: 679196
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of disulfiram (tetraethylthiuram disulfide) amd diethyldithiocarbamate on the bladder toxicity and antitumor activity of cyclophosphamide in mice.
    Hacker MP; Ershler WB; Newman RA; Gamelli RL
    Cancer Res; 1982 Nov; 42(11):4490-4. PubMed ID: 6290038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of benzylpenicillin and doxycycline on toxicity and antineoplastic action of cyclophosphamide and methotrexate in mice].
    Pakulska W
    Acta Pol Pharm; 1992; 49(1-2):35-40. PubMed ID: 8769079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in the toxicity and antitumor activity of methyl-CCNU in mice following pretreatment with either phenobarbital or SKF 525A.
    Klubes P; Miller HG; Cerna I; Trevithick J
    Cancer Treat Rep; 1979; 63(11-12):1901-7. PubMed ID: 526922
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of phenobarbital and SKF 525A on placental transfer of cyclophosphamide in mice.
    Gibson JE; Becker BA
    J Pharmacol Exp Ther; 1971 Apr; 177(1):256-62. PubMed ID: 5566767
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of SKF 525-A, phenobarbital and 3-methylcholanthrene on the toxicity of lobeline sulfate.
    Kim HL
    Vet Hum Toxicol; 1985 Feb; 27(1):1-2. PubMed ID: 3976162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dosage, phenobarbital, and 2-diethylaminoethyl-2,2-diphenylvalerate on the binding of cyclophosphamide and-or its metabolites to the DNA, RNA, and protein of the embryo and liver in pregnant mice.
    Murthy VV; Becker BA; Steele WJ
    Cancer Res; 1973 Apr; 33(4):664-70. PubMed ID: 4696467
    [No Abstract]   [Full Text] [Related]  

  • 18. Circadian dependence of host and tumor responses to cyclophosphamide in mice.
    Cardoso SS; Avery T; Venditti JM; Goldin A
    Eur J Cancer (1965); 1978 Sep; 14(9):949-54. PubMed ID: 710487
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicology of anti-leukemic agents with special reference to phthalanilide derivatives.
    Kensler CJ; Palm PE; Day HM; Battista SP; Rogers WI; Yesair DW; Wodinsky I
    Cancer Res; 1965 Oct; 25(9):1622-37. PubMed ID: 5861081
    [No Abstract]   [Full Text] [Related]  

  • 20. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
    Avery TL; Roberts D
    Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.